post

The Beatson West of Scotland Cancer Centre becomes first Scottish hospital to receive the CSEP accreditation

Clinical Service Excellence Programme // 26th April 2019

In mid-April, the Beatson West of Scotland Cancer Centre (Glasgow), was awarded the Clinical Service Excellence Programme (CSEP) plaque by Myeloma UK, becoming the first Scottish hospital to receive this accreditation.

The award was presented by Shelagh McKinlay, Amy Capper and Hannah Parkin from Myeloma UK to Consultant Haematologist Dr Richard Soutar and Myeloma Clinical Nurse Specialist Audrey Robb.

Myeloma UK were pleased to acknowledge the accomplishments of the small but dedicated team at the Beatson and hope to see more Scottish hospitals applying for CSEP accreditation.

Dr Richard Soutar from the Beatson West of Scotland Cancer Centre said:

“I am very pleased and quite emotional about receiving the Myeloma UK CSEP accreditation! I would definitely recommend and encourage other hospitals to apply to join the programme and work towards the award.”

CSEP was established in 2015 to recognise when superior care is given to myeloma patients, to share best practice initiatives, and to benchmark optimum standards in myeloma treatment. To date, over 20 UK hospitals have received a CSEP accreditation with a further 10 in progress.

Any UK hospital treating myeloma patients is eligible to apply for CSEP. Participation in the programme includes completion of patient experience surveys, a site visit to the hospital and a self-assessment that is completed by the medical team evaluating eight key areas of patient care:

  • new patient experience
  • research and clinical trials
  • multidisciplinary working
  • end of life care
  • diagnosis and follow-up
  • awareness and education
  • treatment and supportive care
  • information and support

We asked Richard and Audrey to share some further perspectives for other hospitals thinking of applying to CSEP.

Did you have any reservations about taking part in the programme and if so, what were these?

Yes, of course: principally how much time it would take to complete the process and how would we address any deficiencies identified.

Were there any particular challenges or surprises you faced during the process?

No, I don’t think there were any surprises – both Myeloma UK and hospital management were very supportive of / during the application process.

How did you find working towards the award?

It was a fairly simple process. It does take a bit of time, especially finding time to distribute and collect patient questionnaires. However, it is worth it to see the feedback

Did you find any additional benefits in working towards the award?

The CSEP process gave us an opportunity to review and reflect on the clinical service we provide, which can otherwise be lacking in the busyness of day-to-day clinical work. The programme is dynamic and even though we have received the CSEP plaque, we will continue to improve our service for myeloma patients. Being part of CSEP helps us do this by implementing the recommendations from Myeloma UK and through the on-going relationship with them for sharing of best practice.

You can apply to join our Programme here, or for more details contact csep@myeloma.org.uk